NRx Pharmaceuticals, Inc. (NRXP) Reports In-Line Q3 EPS
Tweet
Share
E-mailGet Alerts NRXP Hot Sheet
Join SI Premium – FREE
NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) reported Q3 EPS of ($0.14), in-line with the analyst estimate of ($0.14).
For earnings history and earnings-related data on NRx Pharmaceuticals, Inc. (NRXP) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nordson Corp. (NDSN) Tops Q3 EPS by 16c; Offers Guidance
- Bill.com (BILL) Tops Q4 EPS by 14c, Beats on Revenue; Offers FY27 Guidance
- Ocean Power Technologies revises fiscal 2026 results after audit
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
